About Stem Cell biotherapy

Patients with chronic kidney disease that are candidates for dialysis or transplants should consider stem cell biotherapy. This is particularly true with individuals that have persistent impaired renal function as measured by elevated BUN, Creatinine, abnormal 24 hour creatinine clearance test and decreased glomerular filtration rate.

To evaluate your condition it would be desirable for us to review a report on either a renal ultrasound or renal scan. Patients from the age of five years to eighty years are suitable for this type of treatment.

The source of the stem cells is umbilical cord blood and umbilical cord. The blood is carefully screened to rule out HIV, Hepatitis B and C, and Cytomegalovirus.

The patient is also given stem cell growth factor and placed on a specific protocol following treatment to ensure the engraftment, survival and safe proliferation of the cells. Post procedure, the patient is followed once a month with standard kidney function tests including BUN, Creatinine, 24 hour creatinine clearance test and glomerular filtration rate to determine progress.